GlassScriptPhysician profile
Joseph Xin
NPI 1891431979
$1,906.60
in general payments reported to CMS, 2019-2025
21 companies · $544 in 2025
The $544 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $295 · 2023: $580 · 2024: $488 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,611.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $173.69 | 2023 | Orgovyx, Gemtesa |
| Medtronic, INC. | $169.12 | 2024 | Interstim |
| Karl Storz Endoscopy-America | $150.93 | 2023 | N.A. |
| Endo USA, INC. | $150.29 | 2024-2025 | Xiaflex, Aveed |
| Baxter Healthcare | $146.05 | 2025 | Floseal |
| Hollister Incorporated | $141.36 | 2022-2023 | Infyna Chic, Vapro Pocket |
| Astellas Pharma US INC | $134.66 | 2025 | Xtandi |
| Ambu INC. | $121.95 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $121.59 | 2023-2025 | Bard Urinary Drainage Bag |
| 180 Medical, INC. | $107.12 | 2023-2025 | Gentlecath, Gentlecath Glide |
| Antares Pharma, INC. | $89.39 | 2024-2025 | Xyosted |
| Profound Medical Corp. | $76.79 | 2022 | |
| Abbvie INC. | $76.63 | 2024-2025 | |
| Myovant Sciences INC. | $53.85 | 2022 | |
| Tempus Ai, INC | $48.28 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $39.62 | 2023 | |
| Convatec INC. | $26.64 | 2022 | |
| Halozyme INC | $24.91 | 2023 | |
| Merck Sharp & Dohme LLC | $23.85 | 2024 | Keytruda |
| Urovant Sciences INC | $15.06 | 2022 | |
| Pfizer INC. | $14.82 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Xin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.